Unió Europea - eslovè - EMA (European Medicines Agency)

alexion europe sas - ravulizumab - hemoglobinurija, paroksizmal - selektivni imunosupresivi - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healthcare d.o.o. - ibuprofen - šumeča zrnca - ibuprofen 200 mg / 1 vrečica - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

mylan healthcare d.o.o. - ibuprofen - šumeča zrnca - ibuprofen 200 mg / 1 vrečica - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

gsp proizvodi d.o.o. - ibuprofen - šumeča zrnca - ibuprofen 200 mg / 1 vrečica - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - ibuprofen - filmsko obložena tableta - ibuprofen 400 mg / 1 tableta - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi-aventis d.o.o. - ibuprofen - filmsko obložena tableta - ibuprofen 400 mg / 1 tableta - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inn - farm d.o.o. - ibuprofen - filmsko obložena tableta - ibuprofen 200 mg / 1 tableta - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

inn - farm d.o.o. - ibuprofen - filmsko obložena tableta - ibuprofen 200 mg / 1 tableta - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ibuprofen - filmsko obložena tableta - ibuprofen 400 mg / 1 tableta - ibuprofen

Eslovènia - eslovè - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - kvetiapin - filmsko obložena tableta - kvetiapin 200 mg / 1 tableta - kvetiapin